HomeJSPR • NASDAQ
add
Jasper Therapeutics Inc
Previous close
$0.88
Day range
$0.80 - $0.92
Year range
$0.80 - $7.19
Market cap
22.30M USD
Avg Volume
350.47K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 17.65M | -30.21% |
Net income | -9.10M | 62.58% |
Net profit margin | — | — |
Earnings per share | -0.54 | 66.56% |
EBITDA | -17.36M | 30.69% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 28.69M | -59.95% |
Total assets | 35.78M | -55.22% |
Total liabilities | 31.63M | 73.54% |
Total equity | 4.15M | — |
Shares outstanding | 28.00M | — |
Price to book | 5.84 | — |
Return on assets | -94.62% | — |
Return on capital | -472.83% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -9.10M | 62.58% |
Cash from operations | -21.87M | -3.47% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | -340.00K | -198.55% |
Net change in cash | -22.21M | -6.43% |
Free cash flow | -25.45M | -98.75% |
About
Founded
2018
Headquarters
Website
Employees
22
